Admera

What Admera does

Admera Health is a privately held, US-based contract research organization operating a CLIA-certified, CAP-accredited genomics laboratory in South Plainfield, New Jersey. The company provides next-generation sequencing and multi-omics services spanning genomics (WGS, WES, metagenomics), transcriptomics (mRNA-seq, total RNA-seq, single-cell RNA-seq), epigenomics (ChIP-seq, ATAC-seq, EM-seq), spatial transcriptomics, single-cell sequencing across eight validated platforms, plus metabolomics, proteomics, and integrated bioinformatics analysis. Through its October 2024 acquisition of BioEcho, Admera also sells EchoLUTION single-step nucleic acid purification reagent kits, adding a physical-product revenue stream to its services business.

The company serves primarily biopharmaceutical companies conducting drug discovery, biomarker identification, and CRISPR screens, and academic researchers requiring publication-ready data and access to diverse sequencing platforms. Its customer base includes university labs (e.g., Duke University), AI-driven biotech startups (e.g., Tahoe Therapeutics), and clinical-trial service providers (e.g., AltaSciences). Admera positions itself as a differentiated US-only, fully-accredited alternative with industry-leading turnaround times (10-14 days), 99.9% data quality pass-through, and 98.7% on-time delivery, leveraging Certified Service Provider status with major instrument vendors (10x Genomics, PacBio, Parse Biosciences, IDT, Takara Bio).

Revenue is generated through quote-based, project-driven B2B engagements with project-specific pricing determined by sample count, platform selection, sequencing depth, and bioinformatics scope; volume discounts are available. The go-to-market is sales-led with dedicated project managers, PhD-level scientific consultations, and content-driven demand generation via scientific publications, technical blogs, and industry conferences. Revenue is not publicly disclosed and ownership/investor composition is opaque, with the most recent disclosed funding round dating to 2016.

Name

Admera

Legal name

Admera Health, LLC

Website

https://admerahealth.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Admera Health is a US-based, CLIA-certified and CAP-accredited genomics CRO offering multi-omics sequencing, single-cell, spatial, and bioinformatics services to biopharmaceutical companies and academic researchers, plus EchoLUTION reagent kits from its BioEcho acquisition.

Ownership category

akta.pro rank

Product category

Genomics and Multi-omics Research Services

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Proteomics & Mass Spectrometry Services (HLAGANAB)

akta.pro secondary industry

Proteomics & Biomarker Analytical Testing (HLAGADAG)

Keywords

• Next-generation sequencing services
• Multi-omics analysis
• Single-cell sequencing
• Spatial transcriptomics
• Bioinformatics services

Headquarters

HQ city

South Plainfield

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Sequencing Services: Next-generation sequencing services including whole genome, whole exome, transcriptomics, single-cell, spatial transcriptomics, epigenomics. Revenue generated from per-sample or per-project pricing based on sequencing depth and complexity.
2. BioEcho Products: Sale of EchoLUTION nucleic acid extraction kits for RNA, DNA, FFPE, tissue, cell culture, plant, buccal swab, and viral samples. Revenue from product catalog sales.
3. Bioinformatics Analysis Services: Custom bioinformatics analysis services including genomic, transcriptomic, epigenomic, microbiome, single-cell, and spatial analysis. Add-on service to sequencing with custom pricing.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Admera Health is a genomics and multi-omics contract research services provider operating a CLIA-certified, CAP-accredited laboratory in South Plainfield, New Jersey. It delivers next-generation sequencing and bioinformatics analysis across genomics, transcriptomics, epigenomics, single-cell, spatial transcriptomics, proteomics, and metabolomics for biopharmaceutical companies and academic researchers. Following its 2024 acquisition of BioEcho, Admera also sells EchoLUTION single-step nucleic acid extraction kits as a product line.

Product overview

Admera Health is a genomics and multi-omics services company operating a CAP-accredited, CLIA-certified laboratory in South Plainfield, New Jersey. The company provides a comprehensive portfolio of contract research services organized into eight core service areas: Genomics (WGS, WES, metagenomics, amplicon sequencing, custom gene panels), Transcriptomics (mRNA-seq, total RNA-seq, smRNA-seq, scRNA-seq, metatranscriptomics, DRUG-seq, BRB-seq), Epigenomics (ChIP-seq, EM-seq, WGBS, CUT&RUN, ATAC-seq, RRBS, Hi-C), Single-Cell Sequencing (8 platforms including 10x Genomics, Parse Biosciences, Takara Shasta, Singleron), Spatial Transcriptomics (Visium HD, Stereo-seq, Curio), Bioinformatics Analysis, Metabolomics, and Proteomics. The company also offers Sequencing Only services for pre-made libraries and, following the acquisition of BioEcho, sells nucleic acid extraction kits under the BioEcho EchoLUTION brand. Admera Health is a certified service provider for 10x Genomics, PacBio, Parse Biosciences, IDT, and Takara Bio, and supports data delivery via Illumina BaseSpace and secure FTP.

Differentiator

Problem solved

Functional benefit

Brands

• BioEcho: EchoLUTION single-step nucleic acid extraction technology brand offering RNA and DNA purification kits including Cell Culture RNA Kit, Tissue RNA Kit, FFPE RNA Kit, Viral RNA/DNA Kit, Plant DNA Kit, Buccal Swab DNA Kit, FFPE DNA Kit, and EchoCLEAN cleanup kits.

Products and services

• Genomics Services High-throughput sequencing and advanced bioinformatics services for whole genome sequencing (WGS), whole exome sequencing (WES), metagenomics, amplicon sequencing, and custom DNA gene panels, serving biopharma companies and academic researchers.
• Transcriptomics Services RNA sequencing services including mRNA-seq, total RNA-seq, smRNA-seq/miRNA-seq, single-cell RNA-seq, metatranscriptomics, DRUG-seq, and BRB-seq for gene expression analysis, serving biopharma and academic research customers.
• Epigenomics Services NGS-based epigenomic services including ChIP-seq, EM-seq (Enzymatic Methyl-seq), WGBS, CUT&RUN, ATAC-seq, RRBS, and Hi-C Assay for studying DNA modifications and chromatin interactions in research samples.
• Single-Cell Sequencing Services Single-cell RNA sequencing (scRNA-seq) services across 8 validated platforms including 10x Genomics (Chromium 3'/5', Multiome, VDJ, Flex), Illumina, Parse Biosciences Evercode, Takara Shasta, and Singleron GEXSCOPE, for researchers requiring high-resolution single-cell analysis.
• Spatial Transcriptomics Services Whole transcriptome spatial profiling using 10x Genomics Visium HD, STOmics Stereo-seq (including OMNI for FFPE), and Curio spatial biology platforms to map gene expression within tissue architecture for translational and clinical research.
• Bioinformatics Analysis Services Expert bioinformatic analysis services covering genomic, transcriptomic, microbiome, epigenomic, single-cell, and spatial transcriptome data analysis with standardized and custom pipelines, delivering publication-ready results.
• Metabolomics Services Metabolomics services providing functional insights through small molecule metabolite analysis for biomarker discovery, disease mechanism elucidation, pharmacometabolomics, and microbiome-host interactions, for biopharma and academic researchers.
• Proteomics Services Discovery proteomics services using high-resolution mass spectrometry for protein quantification, protein-protein interactions, and post-translational modifications supporting disease research and drug development.
• Sequencing Only Services Cost-effective sequencing services for pre-made libraries using Illumina platforms (NovaSeq X Plus, NovaSeq 6000, NextSeq 1000/2000, MiSeq) and PacBio Revio for long-read sequencing, targeting researchers with pre-prepared libraries.
• BioEcho Purification Products EchoLUTION nucleic acid extraction and purification kits acquired from BioEcho, featuring single-step purification technology for RNA (Cell Culture, Tissue, FFPE, Viral) and DNA (Plant, Buccal Swab, FFPE) with 70% faster protocols and 90% less disposable costs, sold through BioEcho.com catalog.

Quantifiable outcome

• 99.9% data quality pass-through rate
• +3 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Eight partnerships are on record, tiered core.

• American Junior Investigator Association (AJIA)coreStrategic or Co-development Partner · 17 July 2026Admera Health unveiled partnership to provide AJIA members with sequencing services and pilot grants. Supports the America's Got Research competition celebrating next-generation scientific innovators.
• 10x GenomicscoreTechnology or IntegrationCertified Service Provider status for 10x Genomics platforms including Chromium X, Visium CytAssist, and Multiome. Enables single-cell, spatial, and multiomic sequencing services.
• PacBiocoreTechnology or IntegrationPacBio Certified Service Provider for Revio long-read sequencing platform. Enables high-fidelity HiFi sequencing for isoform sequencing and comprehensive genomic analysis.
• Takara BiocoreTechnology or IntegrationFirst Certified Service Provider for Takara Bio's Shasta Single Cell System. Enables scalable single-cell analysis with imaging-based cell selection.
• Parse BiosciencescoreTechnology or IntegrationCertified Service Provider for Parse Biosciences Evercode WT combinatorial barcoding platform. Enables highly scalable single-cell sequencing for large cohorts.
• IlluminacoreTechnology or IntegrationPrimary sequencing platform partner providing NovaSeq X Plus, NovaSeq 6000, NextSeq 1000/2000, and MiSeq systems for short-read sequencing.
• BioEchocoreOEM/ Whitelabel/ Licensing PartnerAdmera Health acquired BioEcho, bringing EchoLUTION single-step nucleic acid purification technology to its genomics offerings. Products sold through BioEcho catalog.
• Old Dominion UniversitycoreStrategic or Co-development PartnerGrant-funded collaboration combining generative AI, single-cell genomics, and explainable bioinformatics to advance Alzheimer's research.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Azenta Life Sciences (formerly Genewiz): Azenta's Genewiz division is the largest independent genomics services CRO, offering Sanger, NGS, and gene synthesis services to academic and biopharma customers. Directly comparable as a B2B genomics services provider with similar customer segments.
• Eurofins Genomics: Eurofins Genomics is a global genomics services division of Eurofins Scientific offering DNA sequencing, genotyping, and oligonucleotide services. Directly competes with Admera in NGS services for academic and biopharma customers at global scale.
• Novogene: Novogene is a leading genomics CRO providing next-generation sequencing, single-cell, and multi-omics services globally with major capacity in the US and Asia. Comparable in service breadth (WGS, RNA-seq, single-cell) and customer base.
• BGI Genomics: BGI Genomics is one of the world's largest genomics services organizations offering WGS, RNA-seq, and clinical sequencing at massive scale. Comparable as a multi-omics service provider, though typically at lower price points and broader global scale.
• Psomagen (formerly Macrogen USA): Psomagen provides NGS, single-cell, and bioinformatics services in the US market, spun off from Macrogen. Comparable mid-sized US-focused genomics CRO serving biopharma and academic customers.
• Macrogen: Macrogen is a Korean-headquartered genomics services company offering Sanger, NGS, and clinical sequencing globally. Comparable in NGS service offerings and academic/biopharma customer base.
• CD Genomics: CD Genomics is a US-based sequencing services CRO offering WGS, RNA-seq, single-cell, and epigenomics services. Directly comparable as a smaller-scale multi-omics services provider targeting academic and biotech customers.
• SeqCenter: SeqCenter is a US-based genomics services provider offering NGS and long-read sequencing. Comparable as a smaller-scale, academic and biotech-focused sequencing services CRO.

Broad incumbents

• Illumina: Illumina is the dominant short-read sequencing platform vendor and a primary supplier to Admera. Overlaps with Admera through its own services offerings (e.g., Illumina Connected Analytics, clinical services) and represents both a key vendor partner and a broad incumbent in the genomics services value chain.
• QIAGEN: QIAGEN is a broad life science tools and molecular diagnostics company offering sample preparation kits, NGS assays, and bioinformatics services. Comparable at the intersection of nucleic acid extraction products (overlapping with BioEcho) and genomics services.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/admerahealth
• Facebookfacebook.com/admerahealth
• LinkedInlinkedin.com/company/admera-health

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Admera